Step Therapy Fail-First Protocols: Documented Treatment Failure for PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

Step therapy protocols require patients to fail on cheaper medications before insurers approve advanced drugs. Each documented failure is objective evidence that the plaintiff's injury is resistant to standard treatment. Learn how to use fail-first records as severity evidence in personal injury cases.

Step therapy -- also called "fail-first" -- is an insurance protocol that requires patients to try and demonstrably fail on one or more lower-tier medications before the insurer will approve coverage for the medication the prescriber actually wants to use. For personal injury plaintiffs, every step therapy failure is a documented, insurer-verified record that standard treatment was insufficient for their injury -- evidence that directly supports claims of injury severity and treatment complexity.

• Step therapy failures are insurer-documented proof that first-line medications were clinically inadequate for the plaintiff's condition
• Each failed step creates a contemporaneous record of treatment insufficiency that cannot be dismissed as subjective
• LienScripts tracks medication progression through its platform, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report documenting the step therapy journey
• Fail-first protocols inadvertently create a chronological record of escalating treatment that mirrors injury severity
• Defense counsel cannot argue that advanced medications were unnecessary when the plaintiff's own insurer required documented failure on alternatives before approving them

How Step Therapy Creates Severity Evidence

Insurance companies implement step therapy to control pharmaceutical spending. The protocol is straightforward: before the insurer will cover Medication C (the one the prescriber wants), the patient must first try Medication A (cheapest), then Medication B (mid-tier), and demonstrate clinical failure on each. "Failure" means the medication did not adequately treat the patient's condition -- documented by the prescriber in follow-up notes and communicated to the insurer through the prior authorization process.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "Step therapy is the insurance company forcing a documented trial-and-failure process. From a clinical perspective, it is often frustrating because we know the patient needs the target medication from the start. But from an evidentiary perspective, it creates an extraordinary record. Each step failure is the treating physician formally certifying that the previous medication was inadequate. By the time the patient reaches the approved medication, you have a paper trail showing multiple failed treatment attempts -- all documented and verified by the insurer."

The Anatomy of a Step Therapy Record

Step 1: Initial Formulary Medication

The plaintiff starts on the insurer's preferred first-line medication -- typically a generic, lower-potency drug. For pain management, this might be naproxen or ibuprofen. For neuropathic pain, it might be amitriptyline at a low dose. The pharmacy record shows the first fill date and the days supply.

Step 2: Documentation of Failure

After an adequate trial period (typically 14 to 30 days), the prescriber documents that the first-line medication was clinically insufficient. This documentation takes multiple forms:

• Progress note stating the medication did not provide adequate relief
• Prescription change to the next-tier medication
• PA submission to the insurer requesting coverage for the next step, citing failure of the previous medication

Step 3: Second-Line Medication Trial

The patient tries the next medication in the step therapy sequence. The pharmacy record shows the new fill overlapping with or replacing the previous medication. Another trial period follows.

Step 4: Final Approval

After documented failure on the required number of steps, the insurer approves the originally requested medication. The pharmacy record captures the fill date for this medication, often weeks or months after the prescriber first determined it was necessary.

Why Step Therapy Evidence Is Unimpeachable

Step therapy documentation is virtually impossible for defense counsel to challenge effectively for three reasons:

First, the documentation was generated by the plaintiff's prescriber for insurance purposes, not litigation purposes. It is contemporaneous clinical evidence created in the ordinary course of medical care.

Second, the insurer itself verified each failure. The insurance company -- an entity with no interest in inflating the plaintiff's claim -- reviewed the clinical documentation and agreed that the prior medication was insufficient before approving the next step.

Third, the pharmacy record independently confirms each step. Fill dates for Medication A, then Medication B, then Medication C create an objective chronological record that matches the clinical documentation.

Using Step Therapy Records in Demand Packages

Every demand package involving step therapy should present the process as a narrative of escalating severity:

1. Initial prescription -- the medication the plaintiff was first prescribed, with fill date
2. Failure documentation -- the prescriber's assessment that the initial medication was inadequate
3. Escalation -- each subsequent medication tried, with fill dates and failure documentation
4. Final medication -- the drug ultimately approved, with an explanation of why the insurer required a multi-step process
5. Treatment delay -- the total time from initial prescription need to final medication access, presented as a period of inadequately managed pain

The MERIT report from LienScripts includes the complete medication progression showing each therapeutic step, with clinical context explaining why each step was necessary and what its failure meant for the plaintiff's treatment trajectory.

Step Therapy and Treatment Delays

A critical but underutilized damages argument is the treatment delay caused by step therapy. If the prescriber believed the plaintiff needed pregabalin from the start but the insurer required trials of gabapentin and amitriptyline first, the plaintiff endured weeks or months of suboptimal treatment. During that period, the plaintiff's pain was inadequately managed -- not because appropriate treatment was unavailable, but because insurance protocols forced a slower path.

This delay is a compensable harm. The pharmacy records document the exact duration: from the date the prescriber first attempted to prescribe the target medication to the date it was actually filled.

Practical Takeaways

Step therapy failures are gifts to plaintiff attorneys disguised as insurance obstacles. Each failed step is a clinically documented, insurer-verified data point proving that standard treatment was insufficient for the plaintiff's condition. Attorneys should request the complete step therapy record from the prescriber's office and correlate it with pharmacy fill dates from LienScripts.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes step therapy progression analysis.

Related Resources

• Prior Authorization Denials as Severity Evidence -- How PA denials document injury severity
• Medication Switches Prove Treatment Failure -- Using medication changes as evidence of treatment complexity
• What Is a MERIT Report? -- Understanding the pharmacist-authored clinical summary